Log in
Propedeutics · Urinary System

Chronic glomerulonephritis

Glomerulonephritis chronica

Chronic glomerulonephritis (CGN) is a long-standing immunoinflammatory kidney disease characterized by primary damage to the glomeruli, with varying degrees of involvement of the tubules and interstitium. The pathology often debuts insidiously, is detected incidentally through urinalysis, and in most cases inevitably leads to chronic kidney disease (CKD).

Main targetGlomerular apparatus of the kidneys (glomeruli)
Basis of pathogenesisDeposition of immune complexes in renal structures
Frequent outcomeRelentless progression to chronic renal failure
Hidden threatLatent onset in adolescents, students, and pregnant women
4 min readFor medical studentsUpdated 09/24/2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Causes (Etiology)

The onset of the immunoinflammatory process in the kidneys is triggered by various factors. Although the exact cause is often difficult to establish, several groups of proven etiologic factors are distinguished:

  • Infectious agents: bacteria (primarily streptococci) and viruses (hepatitis B and C, measles, rubella, cytomegalovirus, herpes simplex virus).
  • Parasitic diseases: malaria, schistosomiasis.
  • Chemical and toxic exposures: organic solvents, alcohol, and heavy metal poisoning (lead, mercury, cadmium).
  • Drug-related factors: administration of vaccines and sera, use of gold preparations or penicillamine.

Note: the use of nonsteroidal anti-inflammatory drugs (NSAIDs) and antibiotics more frequently provokes tubulointerstitial nephritis, but in some situations can also initiate glomerulonephritis.

Pathogenesis and mechanisms of progression

The disease is based on immune disorders. The key mechanism is the formation of immune complexes (ICs) consisting of an antigen, an antibody, and complement. Most frequently, they circulate in the blood and then deposit in the renal filter. Less commonly, complexes form in situ (directly at the site), when antibodies attack the glomerular basement membrane's own structures. The deposition of ICs triggers inflammation, which determines the morphological type of nephritis (mesangial, membranous, fibroplastic, or minimal change disease).

The progression of glomerular sclerosis and nephron loss are driven by several factors:

  1. Role of the mesangium: activation and proliferation of mesangial cells lead to the excessive accumulation of extracellular matrix.
  2. Hemodynamic shifts: intraglomerular hypertension and hyperfiltration damage the filter, increasing protein loss.
  3. Toxicity of proteinuria: massive passage of plasma macromolecules exerts a direct toxic effect on the tubular epithelium. Activated tubular cells release pro-inflammatory factors, causing an interstitial reaction. It has been proven that the rate of CGN progression directly depends on the severity of these tubulointerstitial changes.
Test your knowledgeTasks from the "Propaedeutics" course bank — get answers and explanations instantly.

Clinical forms of CGN

Despite the introduction of morphological classification (based on biopsy), Russian clinical practice actively uses the E.M. Tareev classification, which distinguishes five forms depending on the leading syndrome:

  • Latent: the most common form. There are no clinical symptoms; the pathology is detected only by urinary syndrome (microhematuria and mild proteinuria).
  • Hematuric: erythrocyturia comes to the forefront (more than 20–30 red blood cells per high-power field in the urinary sediment), with periodic episodes of gross hematuria.
  • Hypertensive: persistent blood pressure elevation dominates. Urinary syndrome is minimally expressed, but signs of target organ damage (funduscopic changes, left ventricular hypertrophy) are present.
  • Nephrotic: characterized by massive protein loss (proteinuria > 3.5 g/day). Accompanied by marked edema (ranging from facial puffiness to anasarca with ascites, pleural effusion, and hydropericardium), oliguria, hypoalbuminemia, and hypercholesterolemia.
  • Mixed: a combination of hypertensive and edematous-nephrotic syndromes. This is the prognostically most unfavorable and severe variant of the course.

Principles of treatment

Treatment of chronic glomerulonephritis requires a comprehensive approach. Etiotropic treatment (eliminating the root cause) is rarely performed because the trigger is often already inactive or unknown.

Main areas of therapy:

  • Immunosuppression (pathogenetic therapy): use of glucocorticoids, cytostatics, and cyclosporine to suppress immune inflammation.
  • Nephroprotection: strict maintenance of normal blood pressure (adequate antihypertensive therapy) to slow down glomerular sclerosis.
  • Symptomatic care: prescription of diuretics for edema, and in resistant cases, plasma ultrafiltration.
  • Dietary therapy: mandatory restriction of table salt (especially in hypertensive and nephrotic forms). With the onset of the first signs of renal failure, patients are restricted in their intake of animal proteins.
How to memorize

Memorizing the 5 clinical forms of CGN according to Tareev can be aided by focusing on the main symptom: "Urine" (latent — a little bit, hematuric — blood), "Pressure" (hypertensive), "Protein/Edema" (nephrotic), and "Everything at once" (mixed).

Class and exam questions

Why is proteinuria considered not only a symptom, but also a progression factor in CGN?

Filtered protein macromolecules exert a direct toxic effect on the epithelium of the renal tubules. This prompts tubular cells to produce pro-inflammatory factors, leading to interstitial inflammation and accelerating renal sclerosis.

What is the difference between glomerulonephritis and tubulointerstitial nephritis?

In glomerulonephritis, the morphological substrate is primary damage to the glomeruli. If damage to the tubules and interstitium initially predominates in the biopsy or clinical picture, tubulointerstitial nephritis is diagnosed.

Can chronic glomerulonephritis be completely cured?

As a rule, the disease has a chronic progressive course. The goal of treatment is to achieve stable remission, minimize protein loss, and maximally delay the onset of end-stage chronic kidney disease.

Something unclear? Ask the AIThe AI tutor has read the material on "Chronic glomerulonephritis" and will explain it in simple terms.

What else to study on this topic

  • Pathomorphological classification of CGN (mesangial, membranous, fibroplastic types)
  • Mechanisms of in situ immune complex formation
  • Differential diagnosis of tubulointerstitial nephritis and CGN
  • Criteria and complications of nephrotic syndrome
  • Drugs for pathogenetic therapy of CGN (immunosuppression regimens)

Master the entire topic in the "Propaedeutics" course

This is a summary. The course covers everything tested in classes and exams.

  • Complete guide on "Chronic glomerulonephritis" and another 3,152 pages of the subject
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 113 video lessons on the subject

Other topics in the "Urinary System" section

The entire "Urinary System" section

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.